US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ryder

244.66

-4.0650-1.63%

Volume:99.57K

Turnover:24.51M

Market Cap:9.38B

PE:19.85

High:252.20

Open:252.20

Low:243.54

Close:248.72

52wk High:284.25

52wk Low:157.67

Shares:38.35M

Float Shares:36.85M

Volume Ratio:0.40

T/O Rate:0.27%

Dividend:3.64

Dividend Rate:1.49%

EPS(TTM):12.33

EPS(LYR):11.94

ROE:16.70%

ROA:3.89%

PB:3.26

PE(LYR):20.49

Loading ...

Overview Company News Filings

Press Release: Spin Master to Acquire Creative Play Technology Company, Hapiko Inc.

Press Release: Kelun-Biotech Announces 2026 Interim Results

Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET

Press Release: Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026

Press Release: SIDUS SPACE Reports Second Quarter 2026 Financial Results

Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Press Release: Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Press Release: Cerenome Reports Second Quarter 2026 Financial Results and Business Update

Press Release: Real and Re/max Holdings Securityholders Approve Proposed Combination

Press Release: BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Press Release: 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results

Press Release: First Trust Global Portfolios Management Limited Announces Distribution for Certain Sub-Funds of First Trust Global Funds ICAV

Press Release: Innovative Eyewear Inc. Reports Record Second Quarter 2026 Results

Press Release: Ferrero GROUP to Acquire Purely Elizabeth, a Leading U.S. Modern Wellness BRAND

Press Release: Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth

Press Release: Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights

Press Release: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

Press Release: TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Press Release: Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: Milestone Scientific Reports Financial Results for Second Quarter 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/R/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"R","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"R\",,,,,undefined,":{"symbol":"R","market":"US","secType":"STK","nameCN":"Ryder","latestPrice":244.655,"timestamp":1787596606537,"preClose":248.72,"halted":0,"volume":99565,"delay":0,"changeRate":-0.01634367963975554,"floatShares":36853364,"shares":38346868,"eps":12.325055,"marketStatus":"Trading","change":-4.065,"latestTime":"08-24 14:37:08 EDT","open":252.2,"high":252.2,"low":243.535,"amount":24511262.1688,"amplitude":0.034838,"askPrice":244.59,"askSize":12,"bidPrice":244.47,"bidSize":4,"shortable":3,"etf":0,"ttmEps":12.325055,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-292968000000,"exchange":"NYSE","adjPreClose":248.72,"dividendRate":0.014878,"preHourTrading":{"tag":"盘前","latestPrice":246.48,"preClose":248.72,"latestTime":"09:29 EDT","volume":120,"amount":29610.6696,"timestamp":1787578199999,"change":-2.24,"changeRate":-0.009006,"amplitude":0.013067},"postHourTrading":{"tag":"盘后","latestPrice":249.73,"preClose":249.73,"latestTime":"19:30 EDT","volume":9975,"amount":2491053.51,"timestamp":1787355003488,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.39876,"impliedVol":0.3374,"impliedVolPercentile":0.3426},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"R\",,,,,undefined,":{"symbol":"R","floatShares":36853364,"roa":"3.89%","roe":"16.70%","lyrEps":11.937799,"volumeRatio":0.39876,"shares":38346868,"dividePrice":3.64,"high":252.2,"amplitude":0.034838,"preClose":248.72,"low":243.535,"week52Low":157.67,"pbRate":"3.26","psRate":"0.73","week52High":284.25,"institutionHeld":0.6518,"latestPrice":244.655,"committee":-0.5,"eps":12.325055,"divideRate":0.014878,"volume":99565,"delay":0,"ttmEps":12.325055,"open":252.2,"prevYearClose":191.39,"prevWeekClose":249.73,"prevMonthClose":256.42,"prevQuarterClose":263.77,"fiveDayClose":264.7,"twentyDayClose":268.68,"sixtyDayClose":248.81,"dividendPayoutRate":0.28296082308697096,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0.13157894736842102,"fiveYearAvgDividendRate":0.02341379230026732},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/R\",params:#limit:5,,,undefined,":[{"date":"2026-10-22","symbol":"R","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1792656000000,"name":null,"time":"Pre-MKt","dateTimestamp":1792641600000,"actualEps":null},{"date":"2026-08-24","symbol":"R","amount":1.01,"announcedDate":"2026-07-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-24","defaultRemindTime":1787578200000,"name":"瑞德系统","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-08-24","currency":"USD","dateTimestamp":1787544000000,"payDate":"2026-09-18"},{"market":"US","date":"2026-07-23","symbol":"R","fiscalQuarterEnding":"2026/06","expectedEps":3.7,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1784779200000,"reportTimeType":"pre","actualEps":3.73},{"date":"2026-05-18","symbol":"R","amount":0.91,"announcedDate":"2026-05-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-18","defaultRemindTime":1779111000000,"name":"瑞德系统","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-19","payableDate":"2026-05-18","currency":"USD","dateTimestamp":1779076800000,"payDate":"2026-06-19"},{"market":"US","date":"2026-04-23","symbol":"R","fiscalQuarterEnding":"2026/03","expectedEps":2.29,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1776916800000,"reportTimeType":"pre","actualEps":2.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"R\",market:\"US\",,,undefined,":[{"executeDate":"2016-11-17","recordDate":"2016-11-21","paymentDate":"2016-12-16","value":0.44,"currency":"USD"},{"executeDate":"2017-02-16","recordDate":"2017-02-21","paymentDate":"2017-03-17","value":0.44,"currency":"USD"},{"executeDate":"2017-05-18","recordDate":"2017-05-22","paymentDate":"2017-06-16","value":0.44,"currency":"USD"},{"executeDate":"2017-08-17","recordDate":"2017-08-21","paymentDate":"2017-09-15","value":0.46,"currency":"USD"},{"executeDate":"2017-11-17","recordDate":"2017-11-20","paymentDate":"2017-12-15","value":0.46,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"R\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.5,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":12,"updateTime":1784952000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/R\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"R","date":"2026-08-21","current":20.261979,"percent":0.947111,"low":4.335476,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"high":21.956761,"avg":11.36875,"sd":4.610198,"marketCap":9504271233},"quantilePoints":[{"date":"2021-08-27","current":16.714761,"twenty":-7.755803,"median":9.861819,"eighty":16.769077,"marketCap":4369104918},{"date":"2021-09-03","current":16.395895,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4285755840},{"date":"2021-09-10","current":16.046171,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4194340722},{"date":"2021-09-17","current":16.161374,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4224453937},{"date":"2021-09-24","current":16.916367,"twenty":-7.751218,"median":9.87728,"eighty":16.7724,"marketCap":4421803045},{"date":"2021-10-01","current":17.126202,"twenty":-7.751218,"median":9.87728,"eighty":16.824146,"marketCap":4476652116},{"date":"2021-10-08","current":17.115916,"twenty":-7.751218,"median":9.87728,"eighty":16.86858,"marketCap":4473963436},{"date":"2021-10-15","current":17.229062,"twenty":-7.751218,"median":9.87728,"eighty":16.897726,"marketCap":4503538916},{"date":"2021-10-22","current":18.296749,"twenty":-7.751218,"median":9.87728,"eighty":16.957122,"marketCap":4782623895},{"date":"2021-10-29","current":12.544258,"twenty":-7.746632,"median":9.89274,"eighty":16.972991,"marketCap":4561242691},{"date":"2021-11-05","current":12.858787,"twenty":-7.746632,"median":9.89274,"eighty":16.972991,"marketCap":4675609342},{"date":"2021-11-12","current":12.99464,"twenty":-7.746632,"median":9.89274,"eighty":16.946201,"marketCap":4725007144},{"date":"2021-11-19","current":12.432031,"twenty":-7.746632,"median":9.89274,"eighty":16.881013,"marketCap":4520435811},{"date":"2021-11-26","current":12.601848,"twenty":-7.746632,"median":9.89274,"eighty":16.848905,"marketCap":4582183064},{"date":"2021-12-03","current":11.712896,"twenty":-7.746632,"median":9.89274,"eighty":16.823699,"marketCap":4258949621},{"date":"2021-12-10","current":11.980172,"twenty":-7.746632,"median":9.89274,"eighty":16.771738,"marketCap":4356134427},{"date":"2021-12-17","current":11.548987,"twenty":-7.746632,"median":9.89274,"eighty":16.734025,"marketCap":4199350099},{"date":"2021-12-23","current":11.717326,"twenty":-7.746632,"median":9.89274,"eighty":16.724457,"marketCap":4260560419},{"date":"2021-12-31","current":12.172139,"twenty":-7.746632,"median":9.89274,"eighty":16.688297,"marketCap":4425935669},{"date":"2022-01-07","current":11.528313,"twenty":-7.742047,"median":9.894559,"eighty":16.645088,"marketCap":4191833042},{"date":"2022-01-14","current":11.66269,"twenty":-7.742047,"median":9.894559,"eighty":16.569237,"marketCap":4240693911},{"date":"2022-01-21","current":11.074978,"twenty":-7.742047,"median":9.894559,"eighty":16.518713,"marketCap":4026994725},{"date":"2022-01-28","current":10.665942,"twenty":-7.742047,"median":9.894559,"eighty":16.390958,"marketCap":3878264386},{"date":"2022-02-04","current":10.595062,"twenty":-7.742047,"median":9.894559,"eighty":16.292436,"marketCap":3852491620},{"date":"2022-02-11","current":10.866768,"twenty":-7.742047,"median":9.894559,"eighty":16.266226,"marketCap":3951287224},{"date":"2022-02-18","current":8.156002,"twenty":-7.742047,"median":9.819077,"eighty":16.167134,"marketCap":4232965038},{"date":"2022-02-25","current":8.041976,"twenty":-7.742047,"median":9.683571,"eighty":16.061394,"marketCap":4173785303},{"date":"2022-03-04","current":8.192283,"twenty":-7.742047,"median":9.408015,"eighty":15.879949,"marketCap":4251794953},{"date":"2022-03-11","current":8.208869,"twenty":-7.742047,"median":8.965509,"eighty":15.706321,"marketCap":4260402915},{"date":"2022-03-18","current":8.2995,"twenty":-7.742047,"median":8.822833,"eighty":15.524465,"marketCap":4307440377},{"date":"2022-03-25","current":7.957709,"twenty":-7.742047,"median":8.777473,"eighty":15.400744,"marketCap":4130051128},{"date":"2022-04-01","current":7.287918,"twenty":-7.742047,"median":8.581191,"eighty":15.306166,"marketCap":3782429545},{"date":"2022-04-08","current":6.216252,"twenty":-7.742047,"median":8.486348,"eighty":15.123407,"marketCap":3226235013},{"date":"2022-04-14","current":6.305886,"twenty":-7.742047,"median":8.400577,"eighty":15.064281,"marketCap":3272754960},{"date":"2022-04-22","current":6.644722,"twenty":-7.742047,"median":8.337941,"eighty":15.019858,"marketCap":3448610584},{"date":"2022-04-29","current":5.552093,"twenty":-7.742047,"median":8.266103,"eighty":15.01151,"marketCap":3574453932},{"date":"2022-05-06","current":5.903169,"twenty":-7.742047,"median":8.228212,"eighty":15.01151,"marketCap":3800478057},{"date":"2022-05-13","current":6.644243,"twenty":-7.742047,"median":8.178807,"eighty":15.01151,"marketCap":4277583282},{"date":"2022-05-20","current":6.306669,"twenty":-7.742047,"median":8.111521,"eighty":15.01151,"marketCap":4060252392},{"date":"2022-05-27","current":6.362269,"twenty":-7.742047,"median":8.052823,"eighty":15.01151,"marketCap":4096048068},{"date":"2022-06-03","current":6.481413,"twenty":-7.742047,"median":8.032181,"eighty":15.01151,"marketCap":4172753088},{"date":"2022-06-10","current":6.150194,"twenty":-7.742047,"median":8.016693,"eighty":15.01151,"marketCap":3959513132},{"date":"2022-06-17","current":5.747488,"twenty":-7.742047,"median":7.956055,"eighty":15.01151,"marketCap":3700250164},{"date":"2022-06-24","current":5.650585,"twenty":-7.746632,"median":7.945333,"eighty":15.013418,"marketCap":3637863415},{"date":"2022-07-01","current":5.726042,"twenty":-7.746632,"median":7.897499,"eighty":15.013418,"marketCap":3686443261},{"date":"2022-07-08","current":5.746694,"twenty":-7.746632,"median":7.835691,"eighty":15.013418,"marketCap":3699738798},{"date":"2022-07-15","current":5.766551,"twenty":-7.746632,"median":7.772142,"eighty":15.013418,"marketCap":3712522968},{"date":"2022-07-22","current":5.926204,"twenty":-7.746632,"median":7.442255,"eighty":15.013418,"marketCap":3815307694},{"date":"2022-07-29","current":5.461894,"twenty":-7.746632,"median":6.699881,"eighty":15.013418,"marketCap":4009565771},{"date":"2022-08-05","current":5.457013,"twenty":-7.746632,"median":6.644722,"eighty":15.013418,"marketCap":4005982145},{"date":"2022-08-12","current":5.788269,"twenty":-7.746632,"median":6.481413,"eighty":15.013418,"marketCap":4249156780},{"date":"2022-08-19","current":5.654372,"twenty":-7.746632,"median":6.388625,"eighty":15.013418,"marketCap":4150863032},{"date":"2022-08-26","current":5.604858,"twenty":-7.746632,"median":6.320172,"eighty":15.013418,"marketCap":4114514824},{"date":"2022-09-02","current":5.186429,"twenty":-7.746632,"median":6.234388,"eighty":15.013418,"marketCap":3807346864},{"date":"2022-09-09","current":5.427723,"twenty":-7.746632,"median":6.204433,"eighty":15.013418,"marketCap":3984480387},{"date":"2022-09-16","current":4.997438,"twenty":-7.746632,"median":6.039787,"eighty":15.013418,"marketCap":3668609335},{"date":"2022-09-23","current":4.66409,"twenty":-7.746632,"median":5.934147,"eighty":15.013418,"marketCap":3423898860},{"date":"2022-09-30","current":5.264535,"twenty":-7.746632,"median":5.891255,"eighty":14.984817,"marketCap":3864684883},{"date":"2022-10-07","current":5.515593,"twenty":-7.746632,"median":5.79038,"eighty":14.962577,"marketCap":4048985659},{"date":"2022-10-14","current":5.330787,"twenty":-7.746632,"median":5.747488,"eighty":14.951585,"marketCap":3913319810},{"date":"2022-10-21","current":5.177363,"twenty":-7.746632,"median":5.716511,"eighty":14.921021,"marketCap":3800691558},{"date":"2022-10-28","current":4.875682,"twenty":-7.746632,"median":5.696654,"eighty":14.896597,"marketCap":4105514216},{"date":"2022-11-04","current":4.97415,"twenty":-7.746632,"median":5.677591,"eighty":14.776301,"marketCap":4188428518},{"date":"2022-11-11","current":5.292233,"twenty":-7.746632,"median":5.663293,"eighty":14.711779,"marketCap":4456266838},{"date":"2022-11-18","current":5.380557,"twenty":-7.746632,"median":5.641848,"eighty":14.711779,"marketCap":4530638454},{"date":"2022-11-25","current":5.732059,"twenty":-7.746632,"median":5.632098,"eighty":14.711779,"marketCap":4826617386},{"date":"2022-12-02","current":5.390702,"twenty":-7.746632,"median":5.616713,"eighty":13.024764,"marketCap":4539181140},{"date":"2022-12-09","current":5.00757,"twenty":-7.746632,"median":5.60073,"eighty":12.852585,"marketCap":4216569129},{"date":"2022-12-16","current":5.043377,"twenty":-7.746632,"median":5.579284,"eighty":12.794995,"marketCap":4246719784},{"date":"2022-12-23","current":5.054119,"twenty":-7.746632,"median":5.556738,"eighty":12.683064,"marketCap":4255764981},{"date":"2022-12-30","current":4.987279,"twenty":-7.746632,"median":5.542093,"eighty":12.55727,"marketCap":4199483758},{"date":"2023-01-06","current":4.977134,"twenty":-7.746632,"median":5.530238,"eighty":12.411068,"marketCap":4190941072},{"date":"2023-01-13","current":5.452767,"twenty":-7.746632,"median":5.515593,"eighty":12.297336,"marketCap":4591442276},{"date":"2023-01-20","current":5.542284,"twenty":-7.746632,"median":5.512803,"eighty":12.262396,"marketCap":4666818914},{"date":"2023-01-27","current":5.635978,"twenty":-7.746632,"median":5.512803,"eighty":12.179012,"marketCap":4745713128},{"date":"2023-02-03","current":5.849625,"twenty":-7.746632,"median":5.504687,"eighty":12.076451,"marketCap":4925612037},{"date":"2023-02-10","current":5.754737,"twenty":-7.746632,"median":5.504687,"eighty":12.026911,"marketCap":4845712801},{"date":"2023-02-17","current":5.263255,"twenty":-7.746632,"median":5.498719,"eighty":11.969767,"marketCap":4563242372},{"date":"2023-02-24","current":5.148999,"twenty":-7.746632,"median":5.492154,"eighty":11.969767,"marketCap":4464182332},{"date":"2023-03-03","current":5.301697,"twenty":-7.746632,"median":5.485925,"eighty":11.969767,"marketCap":4596570983},{"date":"2023-03-10","current":4.857486,"twenty":-7.746632,"median":5.474851,"eighty":11.969767,"marketCap":4211440363},{"date":"2023-03-17","current":4.455455,"twenty":-7.746632,"median":5.452767,"eighty":11.969767,"marketCap":3862879398},{"date":"2023-03-24","current":4.499409,"twenty":-7.746632,"median":5.427723,"eighty":11.969767,"marketCap":3900987688},{"date":"2023-03-31","current":4.783503,"twenty":-7.742047,"median":5.424379,"eighty":11.966298,"marketCap":4147297371},{"date":"2023-04-06","current":4.522458,"twenty":-7.742047,"median":5.424379,"eighty":11.966298,"marketCap":3920971304},{"date":"2023-04-14","current":4.579277,"twenty":-7.746632,"median":5.427723,"eighty":11.969767,"marketCap":3970233240},{"date":"2023-04-21","current":4.639312,"twenty":-7.746632,"median":5.394248,"eighty":11.969767,"marketCap":4022283588},{"date":"2023-04-28","current":4.360113,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3618893391},{"date":"2023-05-05","current":4.456979,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3699292590},{"date":"2023-05-12","current":4.543916,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3771449940},{"date":"2023-05-19","current":4.544476,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3771914863},{"date":"2023-05-26","current":4.48342,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3721238329},{"date":"2023-06-02","current":4.478378,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3717054028},{"date":"2023-06-09","current":4.659306,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3867223940},{"date":"2023-06-16","current":4.628498,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3841653212},{"date":"2023-06-23","current":4.605532,"twenty":-7.751218,"median":5.393551,"eighty":11.973235,"marketCap":3822591397},{"date":"2023-06-30","current":4.710279,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":3909531872},{"date":"2023-07-07","current":4.670509,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":3876522387},{"date":"2023-07-14","current":4.972428,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":4127115523},{"date":"2023-07-21","current":5.1696,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":4290768183},{"date":"2023-07-28","current":7.905694,"twenty":-7.755803,"median":5.397863,"eighty":11.976704,"marketCap":4529962569},{"date":"2023-08-04","current":7.943832,"twenty":-7.755803,"median":5.452767,"eighty":11.976704,"marketCap":4551815654},{"date":"2023-08-11","current":8.064602,"twenty":-7.755803,"median":5.493974,"eighty":11.976704,"marketCap":4621017093},{"date":"2023-08-18","current":7.684017,"twenty":-7.755803,"median":5.519009,"eighty":11.976704,"marketCap":4402941508},{"date":"2023-08-25","current":7.629988,"twenty":-7.755803,"median":5.540699,"eighty":11.976704,"marketCap":4371982969},{"date":"2023-09-01","current":8.001039,"twenty":-7.755803,"median":5.556738,"eighty":11.976704,"marketCap":4584595283},{"date":"2023-09-08","current":7.796047,"twenty":-7.755803,"median":5.572744,"eighty":11.976704,"marketCap":4467134947},{"date":"2023-09-15","current":8.072548,"twenty":-7.755803,"median":5.598162,"eighty":11.976704,"marketCap":4625569819},{"date":"2023-09-22","current":8.255292,"twenty":-7.755803,"median":5.622292,"eighty":11.976704,"marketCap":4730282521},{"date":"2023-09-29","current":8.464257,"twenty":-7.755803,"median":5.641349,"eighty":11.976704,"marketCap":4850019220},{"date":"2023-10-06","current":7.874707,"twenty":-7.755803,"median":5.654372,"eighty":11.976704,"marketCap":4512206936},{"date":"2023-10-13","current":8.166304,"twenty":-7.755803,"median":5.677385,"eighty":11.976704,"marketCap":4679291988},{"date":"2023-10-20","current":7.969257,"twenty":-7.755803,"median":5.687122,"eighty":11.976704,"marketCap":4566384378},{"date":"2023-10-27","current":8.466638,"twenty":-7.81017,"median":5.70583,"eighty":11.984307,"marketCap":4131719492},{"date":"2023-11-03","current":8.900778,"twenty":-7.81017,"median":5.736104,"eighty":11.984307,"marketCap":4343579814},{"date":"2023-11-10","current":9.098775,"twenty":-7.81017,"median":5.748824,"eighty":11.984307,"marketCap":4440202303},{"date":"2023-11-17","current":9.541998,"twenty":-7.81017,"median":5.774024,"eighty":11.984307,"marketCap":4656494849},{"date":"2023-11-24","current":9.76815,"twenty":-7.81017,"median":5.792649,"eighty":11.984307,"marketCap":4766857234},{"date":"2023-12-01","current":9.730912,"twenty":-7.81017,"median":5.832915,"eighty":11.984307,"marketCap":4748685115},{"date":"2023-12-08","current":9.643721,"twenty":-7.785279,"median":5.902141,"eighty":11.982239,"marketCap":4706135761},{"date":"2023-12-15","current":10.11964,"twenty":-7.785279,"median":5.934147,"eighty":11.982239,"marketCap":4938384315},{"date":"2023-12-22","current":10.650962,"twenty":-7.785279,"median":6.039787,"eighty":11.982239,"marketCap":5197669436},{"date":"2023-12-29","current":10.469313,"twenty":-7.81017,"median":6.186334,"eighty":11.984307,"marketCap":5109024950},{"date":"2024-01-05","current":10.161419,"twenty":-7.835061,"median":6.212148,"eighty":11.986374,"marketCap":4958772546},{"date":"2024-01-12","current":10.035173,"twenty":-7.835061,"median":6.306669,"eighty":11.986374,"marketCap":4897164629},{"date":"2024-01-19","current":10.137805,"twenty":-7.859952,"median":6.350752,"eighty":11.988442,"marketCap":4947248763},{"date":"2024-01-26","current":10.437525,"twenty":-7.835061,"median":6.413898,"eighty":11.986374,"marketCap":5093512165},{"date":"2024-02-02","current":10.526533,"twenty":-7.835061,"median":6.548928,"eighty":11.986374,"marketCap":5136947963},{"date":"2024-02-09","current":10.603733,"twenty":-7.835061,"median":6.662452,"eighty":11.986374,"marketCap":5174621870},{"date":"2024-02-16","current":11.958272,"twenty":-7.835061,"median":6.699881,"eighty":11.992994,"marketCap":4855058498},{"date":"2024-02-23","current":12.181128,"twenty":-7.835061,"median":6.699881,"eighty":12.003352,"marketCap":4945538144},{"date":"2024-03-01","current":12.341207,"twenty":-7.81017,"median":6.732825,"eighty":12.070758,"marketCap":5010530121},{"date":"2024-03-08","current":12.549959,"twenty":-7.81017,"median":6.732825,"eighty":12.1283,"marketCap":5095283172},{"date":"2024-03-15","current":12.315273,"twenty":-7.81017,"median":6.732825,"eighty":12.192966,"marketCap":5000001022},{"date":"2024-03-22","current":12.709973,"twenty":-7.81017,"median":6.732825,"eighty":12.252055,"marketCap":5160248952},{"date":"2024-03-28","current":12.9324,"twenty":-7.81017,"median":6.732825,"eighty":12.27243,"marketCap":5250554416},{"date":"2024-04-05","current":12.824457,"twenty":-7.835061,"median":6.699881,"eighty":12.310529,"marketCap":5206729706},{"date":"2024-04-12","current":12.753586,"twenty":-7.835061,"median":6.699881,"eighty":12.337386,"marketCap":5177955906},{"date":"2024-04-19","current":11.685063,"twenty":-7.835061,"median":6.699881,"eighty":12.340342,"marketCap":4744135543},{"date":"2024-04-26","current":15.244202,"twenty":-7.81017,"median":6.732825,"eighty":12.359817,"marketCap":5365959126},{"date":"2024-05-03","current":15.528093,"twenty":-7.81017,"median":6.732825,"eighty":12.422817,"marketCap":5465888775},{"date":"2024-05-10","current":15.863035,"twenty":-7.81017,"median":6.732825,"eighty":12.516984,"marketCap":5583788228},{"date":"2024-05-17","current":15.561712,"twenty":-7.81017,"median":6.732825,"eighty":12.565399,"marketCap":5477722549},{"date":"2024-05-24","current":14.992685,"twenty":-7.81017,"median":6.732825,"eighty":12.683064,"marketCap":5277424965},{"date":"2024-05-31","current":15.007626,"twenty":-7.81017,"median":6.732825,"eighty":12.75491,"marketCap":5282684420},{"date":"2024-06-07","current":14.981478,"twenty":-7.81017,"median":6.732825,"eighty":12.826376,"marketCap":5273480373},{"date":"2024-06-14","current":14.965292,"twenty":-7.835061,"median":6.699881,"eighty":12.854653,"marketCap":5267782630},{"date":"2024-06-21","current":15.053696,"twenty":-7.859952,"median":6.696926,"eighty":12.903973,"marketCap":5298901073},{"date":"2024-06-28","current":15.257899,"twenty":-7.926764,"median":6.670331,"eighty":12.934444,"marketCap":5370780294},{"date":"2024-07-05","current":15.332607,"twenty":-7.926764,"median":6.670331,"eighty":13.078605,"marketCap":5397077570},{"date":"2024-07-12","current":15.560467,"twenty":-7.926764,"median":6.670331,"eighty":14.67393,"marketCap":5477284261},{"date":"2024-07-15","current":16.031128,"twenty":-7.926764,"median":6.670331,"eighty":14.798941,"marketCap":5642957098},{"date":"2024-08-02","current":12.046137,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5986929872},{"date":"2024-08-09","current":11.643786,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5786961567},{"date":"2024-08-16","current":11.960789,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5944512353},{"date":"2024-08-23","current":12.044395,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5986064208},{"date":"2024-08-30","current":12.267342,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6096869157},{"date":"2024-09-06","current":11.844961,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5886945719},{"date":"2024-09-13","current":11.837994,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5883483065},{"date":"2024-09-20","current":12.877836,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6400284270},{"date":"2024-09-27","current":12.605247,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6264807907},{"date":"2024-10-04","current":12.39275,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6159196940},{"date":"2024-10-11","current":12.762878,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6343150468},{"date":"2024-10-18","current":12.754684,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6339078000},{"date":"2024-10-25","current":12.285395,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5872418977},{"date":"2024-10-31","current":13.170128,"twenty":-8.0879,"median":6.543636,"eighty":14.807159,"marketCap":6295321107},{"date":"2024-11-08","current":14.050437,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6716108726},{"date":"2024-11-15","current":14.657363,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7006219587},{"date":"2024-11-22","current":14.262772,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6817605237},{"date":"2024-11-29","current":14.937823,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7140279562},{"date":"2024-12-06","current":14.566236,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6962660668},{"date":"2024-12-13","current":14.75026,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7050624311},{"date":"2024-12-20","current":13.771746,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6582894555},{"date":"2024-12-27","current":14.153066,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6765165373},{"date":"2025-01-03","current":13.844294,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6617572530},{"date":"2025-01-10","current":14.016817,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6700038445},{"date":"2025-01-17","current":14.647631,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":7001567664},{"date":"2025-01-24","current":14.644977,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":7000298957},{"date":"2025-01-31","current":14.36894,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6868353493},{"date":"2025-02-07","current":13.879683,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6634488615},{"date":"2025-02-14","current":13.862207,"twenty":-8.03386,"median":6.543636,"eighty":13.316137,"marketCap":6778619352},{"date":"2025-02-21","current":14.292524,"twenty":-7.746632,"median":6.652028,"eighty":13.787317,"marketCap":6989043992},{"date":"2025-02-28","current":13.739137,"twenty":-7.30351,"median":6.732825,"eighty":13.829167,"marketCap":6718437905},{"date":"2025-03-07","current":13.320009,"twenty":-6.938007,"median":7.55689,"eighty":13.830759,"marketCap":6513484306},{"date":"2025-03-14","current":11.737306,"twenty":-6.885604,"median":7.691962,"eighty":13.830759,"marketCap":5739542480},{"date":"2025-03-21","current":11.989848,"twenty":-6.794229,"median":7.780156,"eighty":13.830759,"marketCap":5863035670},{"date":"2025-03-28","current":12.289466,"twenty":-6.704491,"median":7.818294,"eighty":13.830759,"marketCap":6009548949},{"date":"2025-04-04","current":11.830222,"twenty":-6.612788,"median":7.905144,"eighty":13.830759,"marketCap":5784978738},{"date":"2025-04-11","current":11.83449,"twenty":-6.460167,"median":7.944627,"eighty":13.830628,"marketCap":5787065822},{"date":"2025-04-17","current":11.790103,"twenty":-6.392044,"median":7.965682,"eighty":13.830628,"marketCap":5765360151},{"date":"2025-04-25","current":11.457658,"twenty":-6.145958,"median":8.001039,"eighty":13.830759,"marketCap":5751744390},{"date":"2025-05-02","current":11.438717,"twenty":-5.907983,"median":8.021733,"eighty":13.830759,"marketCap":5742236008},{"date":"2025-05-09","current":12.069535,"twenty":4.422322,"median":8.052268,"eighty":13.830759,"marketCap":6058906475},{"date":"2025-05-16","current":12.972115,"twenty":4.465495,"median":8.071753,"eighty":13.830759,"marketCap":6512001555},{"date":"2025-05-23","current":12.379179,"twenty":4.482002,"median":8.092411,"eighty":13.830759,"marketCap":6214347853},{"date":"2025-05-30","current":12.411296,"twenty":4.504369,"median":8.124987,"eighty":13.830759,"marketCap":6230470762},{"date":"2025-06-06","current":12.205416,"twenty":4.52924,"median":8.150819,"eighty":13.830759,"marketCap":6127118782},{"date":"2025-06-13","current":12.324003,"twenty":4.54414,"median":8.183784,"eighty":13.830759,"marketCap":6186649522},{"date":"2025-06-20","current":12.475531,"twenty":4.557695,"median":8.223114,"eighty":13.830891,"marketCap":6262716580},{"date":"2025-06-27","current":13.078349,"twenty":4.57381,"median":8.253849,"eighty":13.830891,"marketCap":6565331177},{"date":"2025-07-03","current":14.129163,"twenty":4.586262,"median":8.30557,"eighty":13.858624,"marketCap":7092839683},{"date":"2025-07-11","current":14.494806,"twenty":4.600504,"median":8.337941,"eighty":13.890852,"marketCap":7276392799},{"date":"2025-07-18","current":14.164574,"twenty":4.608827,"median":8.434859,"eighty":13.981782,"marketCap":7110616224},{"date":"2025-07-25","current":14.307417,"twenty":4.625011,"median":8.858999,"eighty":14.002789,"marketCap":7225245354},{"date":"2025-08-01","current":14.354265,"twenty":4.633104,"median":9.160989,"eighty":14.049906,"marketCap":7248903923},{"date":"2025-08-08","current":14.19918,"twenty":4.650193,"median":9.572878,"eighty":14.097858,"marketCap":7170585902},{"date":"2025-08-15","current":14.709669,"twenty":4.666003,"median":9.666427,"eighty":14.127845,"marketCap":7428382721},{"date":"2025-08-22","current":14.573161,"twenty":4.709831,"median":9.71638,"eighty":14.151964,"marketCap":7359446547},{"date":"2025-08-29","current":15.114344,"twenty":4.783503,"median":9.76815,"eighty":14.198571,"marketCap":7632743808},{"date":"2025-09-05","current":15.23712,"twenty":4.812786,"median":9.833544,"eighty":14.238885,"marketCap":7694745575},{"date":"2025-09-12","current":15.312239,"twenty":4.861125,"median":10.041985,"eighty":14.314092,"marketCap":7732680866},{"date":"2025-09-19","current":14.993992,"twenty":4.931659,"median":10.156878,"eighty":14.354103,"marketCap":7571965760},{"date":"2025-09-26","current":14.909987,"twenty":4.960305,"median":10.2309,"eighty":14.420027,"marketCap":7529543499},{"date":"2025-10-03","current":15.384936,"twenty":4.977731,"median":10.32899,"eighty":14.468748,"marketCap":7769392438},{"date":"2025-10-10","current":14.883332,"twenty":4.997531,"median":10.44025,"eighty":14.503112,"marketCap":7516082589},{"date":"2025-10-17","current":14.752479,"twenty":5.035793,"median":10.493382,"eighty":14.525335,"marketCap":7450001759},{"date":"2025-10-24","current":12.89259,"twenty":5.054716,"median":10.599398,"eighty":14.539205,"marketCap":6472080000},{"date":"2025-10-31","current":13.625069,"twenty":5.097183,"median":10.658452,"eighty":14.539205,"marketCap":6839784859},{"date":"2025-11-07","current":13.479489,"twenty":5.12209,"median":10.73345,"eighty":14.539205,"marketCap":6766703333},{"date":"2025-11-14","current":13.617026,"twenty":5.133219,"median":10.893348,"eighty":14.539205,"marketCap":6835747206},{"date":"2025-11-21","current":13.070093,"twenty":5.152815,"median":11.090483,"eighty":14.539205,"marketCap":6561186775},{"date":"2025-11-28","current":13.873602,"twenty":5.177781,"median":11.196803,"eighty":14.539205,"marketCap":6964548349},{"date":"2025-12-05","current":14.478446,"twenty":5.19145,"median":11.302112,"eighty":14.539205,"marketCap":7268179885},{"date":"2025-12-12","current":15.927014,"twenty":5.207168,"median":11.404144,"eighty":14.629582,"marketCap":7995361262},{"date":"2025-12-19","current":15.296433,"twenty":5.254517,"median":11.451225,"eighty":14.655417,"marketCap":7678809236},{"date":"2025-12-26","current":15.906907,"twenty":5.265027,"median":11.491086,"eighty":14.698585,"marketCap":7985267129},{"date":"2026-01-02","current":15.393755,"twenty":5.303504,"median":11.530528,"eighty":14.710447,"marketCap":7727664842},{"date":"2026-01-09","current":15.285172,"twenty":5.326043,"median":11.631919,"eighty":14.756356,"marketCap":7673156521},{"date":"2026-01-16","current":15.624593,"twenty":5.335095,"median":11.673876,"eighty":14.821626,"marketCap":7843545494},{"date":"2026-01-23","current":15.790281,"twenty":5.381631,"median":11.714373,"eighty":14.842245,"marketCap":7926721154},{"date":"2026-01-30","current":15.476599,"twenty":5.397735,"median":11.740952,"eighty":14.909825,"marketCap":7769252672},{"date":"2026-02-06","current":17.236437,"twenty":5.43372,"median":11.783021,"eighty":14.940109,"marketCap":8652691236},{"date":"2026-02-13","current":16.435376,"twenty":5.467946,"median":11.830222,"eighty":14.977245,"marketCap":8201252704},{"date":"2026-02-20","current":17.329797,"twenty":5.50631,"median":11.845396,"eighty":14.992461,"marketCap":8647568653},{"date":"2026-02-27","current":17.630044,"twenty":5.529122,"median":11.868324,"eighty":15.006515,"marketCap":8797392028},{"date":"2026-03-06","current":16.622636,"twenty":5.543836,"median":11.926274,"eighty":15.027061,"marketCap":8294695177},{"date":"2026-03-13","current":14.692322,"twenty":5.566305,"median":11.961621,"eighty":15.051953,"marketCap":7331468705},{"date":"2026-03-20","current":15.122092,"twenty":5.582426,"median":12.000539,"eighty":15.06114,"marketCap":7545923966},{"date":"2026-03-27","current":15.704285,"twenty":5.607776,"median":12.030258,"eighty":15.075828,"marketCap":7836438314},{"date":"2026-04-02","current":16.252694,"twenty":5.634545,"median":12.044612,"eighty":15.114182,"marketCap":8110094204},{"date":"2026-04-10","current":17.445365,"twenty":5.643595,"median":12.073512,"eighty":15.122356,"marketCap":8705236958},{"date":"2026-04-17","current":17.393509,"twenty":5.667538,"median":12.105673,"eighty":15.140077,"marketCap":8679361186},{"date":"2026-04-24","current":19.000109,"twenty":5.68188,"median":12.153841,"eighty":15.16364,"marketCap":9386054056},{"date":"2026-05-01","current":19.875748,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9818619637},{"date":"2026-05-08","current":18.939802,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9356261972},{"date":"2026-05-15","current":18.097058,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":8939946619},{"date":"2026-05-22","current":18.675857,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9225873242},{"date":"2026-05-29","current":19.487272,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":9626712188},{"date":"2026-06-05","current":20.75217,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10251572129},{"date":"2026-06-12","current":21.956761,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10846639986},{"date":"2026-06-18","current":20.841457,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10295679889},{"date":"2026-06-26","current":20.984003,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10366097542},{"date":"2026-07-02","current":20.833625,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10291810788},{"date":"2026-07-10","current":21.117934,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10432259183},{"date":"2026-07-17","current":21.386578,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10564969375},{"date":"2026-07-24","current":20.671045,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10273509405},{"date":"2026-07-31","current":19.919539,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":9900010911},{"date":"2026-08-07","current":20.237425,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":10058000007},{"date":"2026-08-14","current":20.305322,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":10091745251},{"date":"2026-08-21","current":19.123282,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"marketCap":9504271233}],"updateTime":1787555363220},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"R\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660748276","title":"Press Release: Spin Master to Acquire Creative Play Technology Company, Hapiko Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2660748276","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660748276?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:00","pubTimestamp":1786968000,"startTime":"0","endTime":"0","summary":"speak their ideas to create a printable sticker to color and share.-- Hands-On Creativity: Built to minimize passive screen time and encourage. -- Ink-Free Technology: Ink-free technology delivers crisp outlines, no mess. -- Kid-Empowered AI: Purpose-built for young creators, using kid-safe AI,Stickerbox is COPPA-compliant and prioritizes safety and privacy while. keeping creativity flowing.About Hapiko Inc.Hapiko Inc. is a Brooklyn-based company building creative play technology for the next generation. By combining child-centric design with the possibilities of kid-safe AI, Hapiko is redefining how kids play.About Spin MasterSpin Master Corp.  is a leading global children's entertainment company, creating exceptional play experiences across its three creative centres: Toys, Entertainment and Digital Games. With worldwide toy distribution, Spin Master is best known for award-winning brands including PAW Patrol , Melissa & Doug , Bakugan and Rubik's Cube, and is the global toy licensee","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4555","BK4022","TM","03160","BK4604","BK4588","BK4232","BK4099","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660847374","title":"Press Release: Kelun-Biotech Announces 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660847374","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660847374?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:18","pubTimestamp":1786965480,"startTime":"0","endTime":"0","summary":"CHENGDU, China, Aug. 17, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.  announces its unaudited consolidated results for the period ended 30 June 2026 .Key information is as follows:-- Revenue amounted to approximately RMB 978 million, with sales of. pharmaceutical products reaching RMB 657 million, up by 112% compared to. the same period last year, driven by two factors: expert recognition of. high quality clinical data and shift in treatment paradigms, and. -- The Company has established a comprehensive operational system in China. Company is also pursuing global expansion through international. diversified pathways to progressively achieve independent overseas market. -- Focusing on ADC and novel DC, the Company not only has two ADC products. that have been approved for marketing, but has also built a product. pipeline that is differentiated and complimentary to approved ADCs in. indications, efficacy performance and safety profile. Through the free. diverse","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","RDC","06990","BK4022","BK4190","XBI","BK1161","BK4107","BK4232","BK4581","LU0196878994.USD","BC","LU2487616109.SGD","BK4585","L","BK4588","R","LU0210528500.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484873","title":"Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484873","media":"Dow Jones","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484873?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:00","pubTimestamp":1786964400,"startTime":"0","endTime":"0","summary":"Key recent and second quarter highlights include:-- Completed first-cycle FDA review of the Company's ANDA for. preservative-free ketamine with no drug-related major deficiencies. The. sole remaining item, a manufacturer's attestation on the vial, has been. -- Initiation of commercial scale manufacturing of preservative-free. ketamine building to launch stock of 5 million doses to be ready for. -- Selected by the Defense Advanced Research Projects Agency  as. prime contractor for SPARC-TMS, an FDA-approved Phase 2/3 trial of. NRX-101 with robotic TMS. Anticipated non-dilutive funding exceeds $11.5. -- The Company is advancing its NRX-100 NDA on Real World Evidence from more. than 65,000 patients, leveraging a Presidential Executive Order and. Congressional budget language that encourage FDA use of such evidence in. -- Closed an institutionally-supported, underwritten public offering of. common stock for gross proceeds of $22.3 million, including full exercise. of the underwriters' opti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UMI","BK4007","BK4144","BK4588","PSIL","MDST","AMZA","EIPX","LCLG","NQmain","BK4022","BK4561","BK4581","AMLP","NRXP","EMLP","EIPI","BK4590","TNGY","BK4232","R","MLPA","TPZ","LABU","USAI","ENFR","ET","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659210351","title":"Press Release: Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659210351","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659210351?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:12","pubTimestamp":1786741920,"startTime":"0","endTime":"0","summary":"LITTLE ELM, Texas--(BUSINESS WIRE)--August 14, 2026--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.2 million for the second quarter of 2026 and an operating loss of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4198","R","BK4022","RVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121593","title":"Press Release: SIDUS SPACE Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121593","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121593?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:45","pubTimestamp":1786740300,"startTime":"0","endTime":"0","summary":"spacecraft at Element U.S. Space & Defense's Orlando, Florida facility, a. -- Integrated the Company's proprietary Fortis VPX digital mission computing. platform onto the next LizzieSat spacecraft. Fortis VPX -- Maxima pairs a. quad-core ARM processor and reconfigurable FPGA with an integrated NVIDIA. edge AI/ML engine and an assured positioning, navigation, and timing.  suite, enabling on-board AI inference and autonomous decision. making at the sensor rather than in ground processing. -- Closed a best-efforts registered direct offering on May 29, 2026 of. 19,685,039 shares of Class A common stock (or pre-funded warrants in lieu. thereof) at $5.08 per share, generating gross proceeds of approximately. $100 million before placement agent fees and offering expenses. -- Announced expected inclusion in the Russell 2000, Russell 3000 and. Russell Microcap Indexes in connection with the FTSE Russell annual. reconstitution, effective after market close on June 26, 2026, expanding. Executive ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","ARKX","BK4232","BK4544","SIDU","BK4187","BK4564","BK4615","UFO","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659912921","title":"Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659912921","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659912921?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:30","pubTimestamp":1786739400,"startTime":"0","endTime":"0","summary":"$7.1 Million in revenue for the first nine months of fiscal 2026 from commercial sales of LYMPHIR (R)$17 million in cash and cash equivalents as of June 30, 2026Expanded LYMPHIR commercial and medical","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4161","CTXR","CR","PR","CTOR","PXI","BK4213","ORR","FXN","BK4139","BK4007","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129230","title":"Press Release: Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129230?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:30","pubTimestamp":1786739400,"startTime":"0","endTime":"0","summary":"$7.1 million in revenue for the first nine months of fiscal 2026 as the LYMPHIR(R) launch progressesStrong institutional demand drives growth in total vials ordered and number of institutions ordering","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR","DT","CTOR","PXI","LU0348723411.USD","PR","BK4023","ORR","BK4560","R","BK4232","BK4099","03160","BK4604","BK4213","BK4022","BK4139","FXN","BK4555","LU1169590202.USD","TM","BK4161","BK4588","BK4585","BK4007","CTXR","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659412930","title":"Press Release: Cerenome Reports Second Quarter 2026 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659412930","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659412930?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:15","pubTimestamp":1786738500,"startTime":"0","endTime":"0","summary":"August 3, 2026, with the Company's common stock trading on the Nasdaq. Capital Market under the ticker symbol \"CNSY\"REYOBIQ Development-- Continued enrollment in the ReSPECT-LM multiple-dose clinical trial. As. of June 30, 2026, approximately one-third of patients had been enrolled,with no dose-limiting toxicities observed to date, supporting the. development of a recommended Phase 2 dose/dosing regimen by year-end. -- Continued enrollment in the ReSPECT-GBM Phase 2 trial. Current enrollment. rates indicate full enrollment in 2026 followed by a data readout and a. subsequent End-of-Phase 2 meeting with the U.S. Food and Drug. -- Initial site activation of the ReSPECT-PBC pediatric brain cancer Phase 1. trial at Lurie Children's Hospital. First dosing expected in the third. -- Continued commercial-level manufacturing scale-up and supply chain. enhancement for REYOBIQ drug supplyCNSide CSF Assay Platform-- Performed 232 CNSide cerebrospinal fluid tests during the first half of. 2026 and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSY","BK4099","NCI","R","BK4022","03160","BK4202","BK4588","BK4139","LCLG","BK4555","BK4604","TM","BK4232","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129586","title":"Press Release: Real and Re/max Holdings Securityholders Approve Proposed Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129586","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129586?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:15","pubTimestamp":1786738500,"startTime":"0","endTime":"0","summary":"Securityholder approval moves Real and RE/MAX Holdings closer to creating Real REMAX Group, a leading technology-enabled global real estate platform built on decades of trust and innovationMIAMI & DEN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4078","REET","MAX","BK4022","CFA.SI","BK4077","GLS.SI","JJJ.SI","REAX","CLR.SI","SRU.SI","BK4079","BK4232","RMAX","GPRO","R","SRT.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659012647","title":"Press Release: BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659012647","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659012647?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:00","pubTimestamp":1786737600,"startTime":"0","endTime":"0","summary":"NEW YORK, Aug. 14, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate update.\"We continue to advance and complete the preparations necessary to initiate the Phase 3b ENDURANCE study of NurOwn in ALS, supported by an FDA-agreed protocol under a Special Protocol Assessment,\" said Chaim Lebovits, President and Chief Executive Officer of BrainStorm. \"The recent appointment of Peter Pitts as Executive Chairman represents an important enhancement to our leadership. Peter is joining the Company in an active executive capacity and will help lead the regulatory, operational, partnership and capital-markets initiatives surrounding the NurOwn program. His experience as a former senior FDA official brings an additional level of regulatory insight and strategic perspective as we prepare to enter this next pha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4022","BK4539","BK4139","BK4007","LENZ","BCLI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659612699","title":"Press Release: 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659612699","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659612699?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:47","pubTimestamp":1786736820,"startTime":"0","endTime":"0","summary":"WASHINGTON, Aug. 14, 2026  -- 60 Degrees Pharmaceuticals, Inc.  , a pharmaceutical company focused on developing new medicines for vector-borne diseases, reported today its financial results for the second quarter of 2026, ended June 30, 2026.Financial Highlights for the Quarter Ended June 30, 2026:-- Net product revenues increased approximately 106% to approximately $208. thousand for the second quarter of 2026, from approximately $101 thousand. -- Gross profit on product revenues was approximately $57 thousand for the. second quarter of 2026, compared with approximately $51 thousand for the. -- Operating expenses were approximately $2.33 million for the second. quarter of 2026, compared with approximately $1.86 million for the second. -- Net loss attributable to common stockholders was approximately $2.40. million, or $0.90 per share, for the second quarter of 2026, compared. with a net loss of approximately $1.84 million, or $5.01 per share, for","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4022","BK4007","R","PRTO","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659125424","title":"Press Release: First Trust Global Portfolios Management Limited Announces Distribution for Certain Sub-Funds of First Trust Global Funds ICAV","url":"https://stock-news.laohu8.com/highlight/detail?id=2659125424","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659125424?lang=en_us&edition=fundamental","pubTime":"2026-08-15 02:21","pubTimestamp":1786731660,"startTime":"0","endTime":"0","summary":"IE000SNMGYT5  First Trust Vest S&P 500         Monthly     $0.1493 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","USD","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659128686","title":"Press Release: Innovative Eyewear Inc. Reports Record Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659128686","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659128686?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:45","pubTimestamp":1786722300,"startTime":"0","endTime":"0","summary":"Y-O-Y Second Quarter Revenue Increased 74% & Gross Margin Improved to 24%MIAMI, Aug. 14, 2026 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ: LUCY, LUCYW), (\"Innovative Eyewear\" or the \"Company\") th","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4022","LUCY","BK4198","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659404531","title":"Press Release: Ferrero GROUP to Acquire Purely Elizabeth, a Leading U.S. Modern Wellness BRAND","url":"https://stock-news.laohu8.com/highlight/detail?id=2659404531","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659404531?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:00","pubTimestamp":1786719600,"startTime":"0","endTime":"0","summary":"LUXEMBOURG and BOULDER, Colo., Aug. 14, 2026 /PRNewswire/ -- Ferrero. Group today announced it has signed an agreement to acquire Purely. Elizabeth, the high-growth modern wellness brand and a leading. better-for-you food company based in the U.S. The acquisition further. enhances Ferrero's relevance at the American breakfast table with Purely. Elizabeth joining its portfolio. Following closing, Ferrero intends to. support Purely Elizabeth's next phase of growth through continued. helping the brand reach more consumers while preserving its distinct. Founded in 2009 and based in Boulder, Colorado, Purely Elizabeth has. more than doubled its sales in the past two years, driven by its. innovative portfolio of granola, oatmeal and cereals while more recently. leading position and helped shape evolving consumer expectations around. breakfast and wellness by pioneering premium and taste-forward products. \"Purely Elizabeth, with its terrific portfolio of quality, tasty. products, is a great a","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659144159","title":"Press Release: Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659144159","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659144159?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:15","pubTimestamp":1786713300,"startTime":"0","endTime":"0","summary":"compared to the second quarter of 2025, marking the strongest quarterly. revenue performance since the fourth quarter of 2024. The increase. reflects continued execution of Lifeward's commercial strategy and. -- Strengthened the Company's balance sheet to a proforma cash balance of. approximately $11 million. The Company had a cash balance of $9.4 million. as of June 30, 2026. Through a strategic financing closed on July 6,2026, providing up to $11.2 million in growth capital, Lifeward raised. approximately $5.6 million, $4.1 million of which was received during the. second quarter, and $1.5 million was received in July. An additional. approximately $5.6 million is available upon achieving either a 150%. increase in ReWalk sales or the Company's common stock trading at $13.80. rehabilitation and durable medical equipment distribution partners while. building scalable commercial infrastructure designed to support portfolio. Care, a leading U.S. mobility technology patient care organizat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4232","BK4555","BK4022","R","BK4604","03160","TM","BK4585","BK4099","LFWD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659614134","title":"Press Release: Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659614134","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659614134?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:30","pubTimestamp":1786710600,"startTime":"0","endTime":"0","summary":"-- Clene expects to submit a New Drug Application for CNM-Au8 in ALS. under the accelerated approval pathway in early fourth quarter of 2026. -- Clene announces survival and functional benefit in CNM-Au8-treated","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089279066.USD","LU1923621640.USD","BK4585","LU2125910336.SGD","LU2229751404.USD","BK4539","LABU","CNM","LU2125910179.SGD","BK4139","CLNN","BK4232","BK4588","R","BK4104","IE0009354923.USD","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659714620","title":"Press Release: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659714620","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659714620?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:00","pubTimestamp":1786708800,"startTime":"0","endTime":"0","summary":"-- Increased patient onboarding at OSU-The James as commercial phase. of strategic engagement accelerated and clinical rollout continued. -- Continued development of the implantable physiological monitor. toward an early 2027 FDA 510 submission, with design freeze. nearing completion and manufacturing test runs performing well in. preliminary verification and validation ahead of final clinical. -- Lucid Diagnostics announced second quarter 2026 financial results and key. -- Recognized $1.5 million in EsoGuard Esophageal DNA Test revenue. -- Secured first laboratory benefit manager coverage po","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAVM","LUCD","BK4022","BK4232","R","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659616146","title":"Press Release: TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659616146","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659616146?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:45","pubTimestamp":1786707900,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., Aug. 14, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc.  , a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today reported financial results for the Company's second quarter ended June 30, 2026, and provided a corporate update.\"We have made significant progress in advancing all our programs forward and are positioned to continue driving towards several anticipated milestones targeted for the second half of the year,\" said Dr. James Bianco, President and CEO of TuHURA Biosciences. \"In the second half, we anticipate receiving safe-to-proceed feedback from FDA and to initiating our Phase 1b/2 trial of VISTA in mutNPM1 r/r AML, initiating our in vivo POC studies for MDSC Inhibitors , potentially receiving orphan drug designation in Merkel cell carcinoma  for IFx-2.0, and potentially receiving orphan drug designation in AML for TBS-2025. The recent $50 million term credit facility made available to us by our largest ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4139","BK4232","R","HURA","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659450691","title":"Press Release: Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659450691","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659450691?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:30","pubTimestamp":1786707000,"startTime":"0","endTime":"0","summary":"Open Medicine AI Established as a Separate Company with Executed Commercial Licenses; Progression-Free Survival Benefit Deepens in EGFR Exon 21 L858R Lung Cancer with LP-300; EMA Clears LP-184, zirdafulven, for Biomarker-Selected Bladder Cancer Trial; LP-184 Development Positioned to Advance in Multiple Indications including Triple Negative Breast Cancer and Pediatric Brain Cancers--  Open Medicine AI  established as a separate company with. withZeta.ai. OMAI is currently wholly owned by Lantern and intends to. raise capital at the OMAI level. A dedicated OMAI informational call is. planned for mid-September 2026 to detail the market opportunity, platform. --  LP-300 -- HARMONIC benefit deepens with treatment duration in. emerging dataset: Median progression-free survival of 8.9 months in EGFR. exon 21 L858R patients who completed six cycles of LP-300 (n=9), compared. with 8.4 months across the overall L858R cohort , and a hazard. clinical benefit rate and tumor reduction in more than ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","R","VGT","BK4081","BK4139","BK4232","LTRN","ARTY","TM","BK4099","BK4022","BK4604","AGIX","VTHR","AIPO","CHAT","EMA","QTOC","03160","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145061","title":"Press Release: Milestone Scientific Reports Financial Results for Second Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145061","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145061?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:30","pubTimestamp":1786707000,"startTime":"0","endTime":"0","summary":"Medical Segment Revenue Grows 231% Year-Over-YearEnters Strategic Distribution Agreement to Expand CompuFlo(R) Access Across VA and Department of Defense Health SystemsReaffirms 2026 Outlook for Doubl","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4082","IE00B66KJ199.SGD","TM","R","IE0031619046.USD","IE00B7SZL793.SGD","MLSS","BK4109","03160","BK4099","BK4179","IE00B19Z4B17.USD","BK4585","BK4555","BK4604","ASPN","BK4022","BK4232"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}